Werewolf Therapeutics, Inc.
HOWL
$1.34
$0.064.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.13% | -74.15% | -88.70% | -66.56% | -31.20% |
| Total Depreciation and Amortization | -5.21% | -1.50% | 2.83% | 6.45% | 8.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | 3.37% | -4.29% | 13.15% | 8.64% | 17.33% |
| Change in Net Operating Assets | -48.54% | 112.73% | 142.86% | 130.48% | 104.76% |
| Cash from Operations | -47.40% | -57.43% | -72.29% | -16.60% | 12.50% |
| Capital Expenditure | 76.97% | 79.92% | 66.97% | 69.79% | 80.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.97% | 79.92% | 66.97% | 69.79% | 80.62% |
| Total Debt Issued | -100.00% | -- | -25.00% | -25.00% | -25.00% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -90.32% | -88.36% | 28.92% | 192.35% | 41.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -366.01% | -545.70% |
| Cash from Financing | -85.10% | -123.88% | -77.61% | -61.26% | -68.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.82% | -675.71% | -273.12% | -383.03% | -289.99% |